Clinical Trial Detail

NCT ID NCT03526835
Title A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Merus N.V.
Indications

colorectal cancer

Advanced Solid Tumor

Therapies

MCLA-158

Age Groups: adult senior

No variant requirements are available.